Leukemia Clinical Trials
There are 31 registered clinical trials for Leukemia in the TrialLens index.
Trials (31)
- Lactation Outcomes Among Survivors of Pediatric Cancer N/A · St. Jude Children's Research Hospital
- Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells Phase 1 · Baylor College of Medicine
- Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome Phase 1/2 · M.D. Anderson Cancer Center
- Simulation Training for Adolescent Leukemia Care in Nursing Students N/A · Atılım University
- Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers N/A · Rutgers, The State University of New Jersey
- Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Phase 3 · Jonsson Comprehensive Cancer Center
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia Phase 3 · Children's Oncology Group
- Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies N/A · M.D. Anderson Cancer Center
- Phase I Study of Sequential Cord Blood Transplants Phase 1 · Massachusetts General Hospital
- Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer Phase 1 · Roswell Park Cancer Institute
- Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant N/A · Julius-Maximilians University
- Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia N/A · Children's Oncology Group
- AMG 319 Lymphoid Malignancy FIH Phase 1 · Amgen
- Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders Phase 2 · City of Hope Medical Center
- Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes Phase 1 · Jonsson Comprehensive Cancer Center
- MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis Phase 2/3 · National Research Center for Hematology, Russia
- Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood Phase 1 · M.D. Anderson Cancer Center
- Breath Analysis for the Detection of Invasive Fungal Infections N/A · University of Zurich
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer N/A · Children's Oncology Group
- Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia Phase 2 · European Organisation for Research and Treatment of Cancer - EORTC
- Metabolic Syndrome in Childhood Cancer Survivors N/A · University of Minnesota
- A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy Phase 2 · National Cancer Institute (NCI)
- Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia Phase 2 · Genta Incorporated
- S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Phase 2 · SWOG Cancer Research Network
- RAT-HEMATO : Return to Work After Malignant Hemopathy N/A · University Hospital, Angers
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia Phase 3 · Eastern Cooperative Oncology Group
- Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) Phase 3 · M.D. Anderson Cancer Center
- A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia Phase 1 · NCIC Clinical Trials Group
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Phase 1 · Pediatric Brain Tumor Consortium
- Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) Phase 3 · University of Florida
- Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML Phase 3 · Daiichi Sankyo
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.